Published in Cancer on October 01, 1978
Interaction of human serum albumin with anticancer agents in vitro. Br J Cancer (1980) 0.77
Fever as a cause of hypophosphatemia in patients with malaria. PLoS One (2007) 0.75
Hypersensitivity reactions from taxol. J Clin Oncol (1990) 3.83
Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood (1968) 2.71
Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects. J Clin Endocrinol Metab (1971) 2.48
Hemangioendothelial sarcoma of liver from chronic arsenic intoxication by Fowler's solution. Cancer (1968) 2.22
Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies. N Engl J Med (1975) 2.16
Amputation and adriamycin in primary osteosarcoma. N Engl J Med (1974) 2.04
An intensive sequenced adjuvant chemotherapy regimen for breast cancer. Cancer Invest (1993) 1.94
Oncologists' reply: survival expectancy in acute lymphocytic leukemia. N Engl J Med (1972) 1.89
Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med (1985) 1.83
Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study. Blood (1982) 1.79
Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. J Urol (2000) 1.78
Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. Ann Intern Med (1982) 1.75
Detection of mammary tumor virus env gene-like sequences in human breast cancer. Cancer Res (1995) 1.75
Elevated serum ribonuclease in patients with pancreatic cancer. Proc Natl Acad Sci U S A (1976) 1.74
Adjuvant chemotherapy of breast cancer. Cancer (1979) 1.73
Quantification of arabinitol in serum by selected ion monitoring as a diagnostic technique in invasive candidiasis. J Clin Microbiol (1980) 1.70
Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B. J Natl Cancer Inst (1996) 1.70
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B. Blood (1981) 1.68
An opportunistic infection with Corynebacterium pyogenes producing empyema. Am J Clin Pathol (1970) 1.62
A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B. J Clin Oncol (1989) 1.56
Reovirus infection of cancer cells is not due to activated Ras pathway. Cancer Gene Ther (2008) 1.56
Chemotherapy of acute lymphocytic leukemia of childhood. Cancer (1972) 1.50
Management of hypocalcemic effects of WR2721 administered on a daily times five schedule with cisplatin and radiation therapy. The New York Gynecologic Oncology Group. J Clin Oncol (1993) 1.46
Diffuse pulmonary malignant mesothelioma: response to doxorubicin and 5-azacytidine. Cancer (1978) 1.45
BOMM regimen for the treatment of advanced head and neck carcinoma. Cancer Invest (1991) 1.42
Fluorometric investigations of the interaction of polyene antibiotics with sterols. Biochemistry (1972) 1.42
Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin Exp Metastasis (1999) 1.42
Diaminodichloroplatinum: a phase I study showing responses in testicular and other tumors. Cancer (1974) 1.42
Identification of a proviral structure in human breast cancer. Cancer Res (2001) 1.37
Biochemical and pharmacological studies with asparaginase in man. Cancer Res (1970) 1.34
Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation). Am J Obstet Gynecol (1983) 1.33
Enzymes in cancer. Asparaginase from chicken liver. Biochem J (1967) 1.32
Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia. Cancer Chemother Rep (1974) 1.30
Role of murine tumor models in cancer treatment research. Cancer Res (1986) 1.30
Lymphocyte function of Michigan dairy farmers exposed to polybrominated biphenyls. Science (1978) 1.30
A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients. Cancer (1973) 1.29
Melphalan in multiple myeloma. Blood (1967) 1.25
Surgical treatment of spinal cord compression from epidural metastasis. J Clin Oncol (1995) 1.25
The effectiveness of combinations of antileukemic agents in inducing and maintaining remission in children with acute leukemia. Blood (1965) 1.23
Lateral diffusion in nuclear membranes. J Cell Biol (1985) 1.22
Therapeutic effect and toxicity of adriamycin in patients with neoplastic disease. Cancer (1971) 1.21
The frequency of long-term remission in patients with acute myelogenous leukaemia treated with conventional maintenance chemotherapy: a study of 760 patients with a minimal follow-up time of 6 years. Br J Haematol (1989) 1.21
Increase of leukemia L1210 immunogenicity by Vibrio cholerae neuraminidase treatment. Cancer Res (1971) 1.20
Height, weight, and alcohol consumption in relation to the risk of colorectal cancer in Japan: a prospective study. Br J Cancer (2003) 1.18
Fungal infection in acute leukemia. Cancer (1972) 1.17
Lack of an association of estrogen receptor alpha gene polymorphisms and transcriptional activity with Alzheimer disease. Arch Neurol (2000) 1.17
Management of patients with malignant lymphoma: a comparative study with cyclophosphamide and vinca alkaloids. Cancer Res (1968) 1.16
Doxorubicin in disseminated osteosarcoma. JAMA (1972) 1.15
Effects of a prolonged 3-hour sleep-wake cycle on sleep stages, plasma cortisol, growth hormone and body temperature in man. J Clin Endocrinol Metab (1974) 1.15
Intracerebral involvement in Hodgkin's disease: a report of 6 cases and review of the literature. Cancer (1979) 1.14
Improved chemotherapy for ovarian cancer with cis-diamminedichloroplatinum and adriamycin. Cancer (1981) 1.10
Epidemic acute leukemia. N Engl J Med (1970) 1.10
A phase I-II study of intensive-dose adriamycin for advanced breast cancer. J Clin Oncol (1987) 1.10
Ethics for a clinical investigator. Non primum non nocere. Am J Med (1979) 1.09
Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B. J Clin Oncol (1987) 1.08
Leukemia-specific DNA sequences in leukocytes of the leukemic member of identical twins. Proc Natl Acad Sci U S A (1973) 1.08
Vincristine treatment of advanced cancer: a cooperative study of 392 cases. Cancer Res (1973) 1.07
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study. J Clin Oncol (1996) 1.07
Search for mouse mammary tumor virus-like env sequences in cancer and normal breast from the same individuals. Clin Cancer Res (2001) 1.07
Effects of hyaluronidase on doxorubicin penetration into squamous carcinoma multicellular tumor spheroids and its cell lethality. J Cancer Res Clin Oncol (1994) 1.06
Editorial: Major advance in breast-cancer therapy. N Engl J Med (1976) 1.06
Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. N Engl J Med (1987) 1.06
Possibilities of a viral etiology for human breast cancer. A review. Biol Trace Elem Res (1997) 1.06
Marker profiles of human leukemia and lymphoma cell lines. J Cancer Res Clin Oncol (1981) 1.06
Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine. Clin Cancer Res (1998) 1.06
MMTV-like env gene sequences in human breast cancer. Arch Virol (2001) 1.05
Corticosteroid administration and localized leukocyte mobilization in man. N Engl J Med (1972) 1.05
Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes. Leukemia (1993) 1.05
Venous thrombosis during multimodal treatment of primary breast carcinoma. Cancer Treat Rep (1981) 1.04
The prophylactic treatment of thrombocytopenic leukemic patients with platelets: a double blind study. Transfusion (1974) 1.04
Leukocyte-derived interferon (alpha) in human breast carcinoma. The American Cancer Society phase II trial. Ann Intern Med (1982) 1.03
Kinetic and comparative studies on localized leukocyte mobilization in normal man. J Lab Clin Med (1969) 1.03
Association of certain Ia allotypes with the occurrence of chronic lymphocytic leukemia. Recognition by a monoclonal anti-Ia reagent of a susceptibility determinant not in the DR series. J Exp Med (1982) 1.03
5-allyl-2'-deoxyuridine inhibition of nucleoside phosphorylase in HeLa cells containing mycoplasma. Cancer Res (1967) 1.02
Microbiological assay of bleomycin: inactivation, tissue distribution, and clearance. Cancer (1974) 1.02
Thrombotic thrombocytopenic purpura: a ten-year experience. Blood (1980) 1.02
Diamminodichloroplatinum in the chemotherapy of testicular tumors. J Urol (1974) 1.02
Lipids trigger changes in the elasticity of the cytoskeleton in plant cells: a cell optical displacement assay for live cell measurements. J Cell Biol (1994) 1.01
Observations on cell lines derived from a patient with Hodgkin's disease. Cancer Res (1978) 1.01
The variability of individual tolerance to methotrexate in cancer patients. Br J Cancer (1971) 1.01
High frequency of clonal immunoglobulin or T cell receptor gene rearrangements in acute myelogenous leukemia expressing terminal deoxyribonucleotidyltransferase. J Exp Med (1987) 1.00
Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts. Endocrinology (1998) 0.99
Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a Cancer and Leukemia Group B study. J Clin Oncol (1988) 0.99
Acute reversal of the sleep-waking cycle in man. Effect on sleep stage patterns. Arch Neurol (1970) 0.99
Inhibitory effect of magnesium L-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo. J Am Acad Dermatol (1996) 0.99
Determination of polyols in serum by selected ion monitoring. Clin Chem (1984) 0.98
Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture. Cancer Res (1988) 0.98
Vincristine-induced bladder atony. Cancer (1971) 0.97
Experiemental and clinical studies on muramidase (lysozyme). I. Muramidase activity of normal human blood cells and inflammatory exudates. Acta Haematol (1970) 0.97
Sequences homologous to the mouse mammary tumor virus env gene in human breast carcinoma correlate with overexpression of laminin receptor. Clin Cancer Res (1999) 0.96
Effect of vincristine (NSC-67574) on malignant solid tumors in children. Cancer Chemother Rep (1968) 0.96
Karnofsky Memorial Lecture. Breaking the cure barrier. J Clin Oncol (1983) 0.95
Expression of mouse mammary tumor virus-like env gene sequences in human breast cancer. Clin Cancer Res (1998) 0.95